Combination Therapy with Betamethasone and Josamycin Demonstrates Superior Therapeutic Efficacy in an NC/Nga Mouse Model of Atopic Dermatitis
Biological and Pharmaceutical Bulletin · 2023
DOI: 10.1248/bpb.b22-00781 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biological and Pharmaceutical Bulletin, 2023. Verfasst von Katsuhiko Matsui und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Immunology, Meiji Pharmaceutical University. Hauptthemen laut MEDLINE: Dermatitis, Atopic. Die Arbeit nennt 30 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Immunology, Meiji Pharmaceutical University.
Zitieren
APA
Matsui, K., Muranaka, M., Yamaguchi, T., & Maeda, M. (2023). Combination Therapy with Betamethasone and Josamycin Demonstrates Superior Therapeutic Efficacy in an NC/Nga Mouse Model of Atopic Dermatitis. Biological and Pharmaceutical Bulletin. https://doi.org/10.1248/bpb.b22-00781
Vancouver
Matsui K, Muranaka M, Yamaguchi T, Maeda M. Combination Therapy with Betamethasone and Josamycin Demonstrates Superior Therapeutic Efficacy in an NC/Nga Mouse Model of Atopic Dermatitis. Biological and Pharmaceutical Bulletin. 2023. doi:10.1248/bpb.b22-00781
BibTeX
@article{Matsui2023,
author = {Matsui, Katsuhiko and Muranaka, Madoka and Yamaguchi, Tomoka and Maeda, Manami},
title = {Combination Therapy with Betamethasone and Josamycin Demonstrates Superior Therapeutic Efficacy in an NC/Nga Mouse Model of Atopic Dermatitis},
journal = {Biological and Pharmaceutical Bulletin},
year = {2023},
doi = {10.1248/bpb.b22-00781}
}
EUVIMED